Results 41 to 50 of about 183,492 (354)
Heterogeneity of non‐alcoholic fatty liver disease [PDF]
Liver International, 2015 See Article on Page ...
Yki‐Järvinen, Hannele +1 more
openaire +2 more sources
Non-alcoholic fatty liver disease and liver secretome
Archives of Pharmacal Research, 2022 Metabolism of carbohydrates and lipids and protein degradation occurs in the liver and contributes to the body's homeostasis by secreting a variety of mediators. Any imbalance in this homeostasis due to excess fat consumption and the pathologic events accompanying lipotoxicity, autophagy dysregulation, endoplasmic reticulum stress, and insulin ...
Muhammad Sohaib Khan +2 more
openaire +2 more sources
BMC Medicine, 2022 Background The relationship between non-alcoholic fatty liver degree as well as non-alcoholic fatty liver disease (NAFLD) and irritable bowel syndrome (IBS) remains poorly understood.
Shanshan Wu +6 more
doaj +1 more source
Chemokines modulate chondrocyte homeostasis: implications in osteoarthritis [PDF]
, 2004 Non-alcoholic steatohepatitis (NASH) is an underdiagnosed liver disease characterized by steatosis, necroinflammation and fibrosis. This disease may eventually develop into cirrhosis and hepatocellular carcinoma.
Rai, M.F., Cotton, R., Sandell, L.J.
core +1 more source
Diagnosis of Non-alcoholic fatty liver disease
Journal of Pathology of Nepal, 2016 Non Alcoholic Fatty Liver Disease is the deposition of fat in liver in absence of excessive of alcohol consumption. Non Alcoholic Fatty Liver Disease ranges from simple steatosis to Nonalcoholic steatohepatitis and cirrhosis.
Geetika K.C.
doaj +1 more source
BMC Endocrine Disorders, 2021 Background Non-alcoholic fatty liver disease (NAFLD) is a common disorder that is known to be the leading cause of chronic liver disease worldwide.
Nader Salari +6 more
doaj +1 more source
The Role of Insulin Resistance in Diabetic Patients with Chronic Liver Disease [PDF]
, 2008 Background: The association between diabetes and chronic liver disease has been well documented. However, the mechanism remains unknown. The aim of this study was to investigate the insulin resistance in chronic liver disease and normal liver in diabetic
Bayupurnama, P. (Putut) +3 more
core +1 more source
Non-alcoholic fatty liver disease and liver transplantation [PDF]
Metabolism, 2016 Cirrhosis secondary to non-alcoholic steatohepatitis (NASH) is a common indication for liver transplant. In comparison to other cirrhotic patients, patients with NASH cirrhosis are more likely to be older and have the metabolic syndrome. Pre-transplant, patients require careful evaluation of cardiovascular risk.
Reenam S, Khan, Philip N, Newsome
openaire +2 more sources
Platelets in Non-alcoholic Fatty Liver Disease [PDF]
Frontiers in Pharmacology, 2022 Non alcoholic steatohepatitis (NASH) is the inflammatory reaction of the liver to excessive accumulation of lipids in the hepatocytes. NASH can progress to cirrhosis and hepatocellular carcinoma (HCC). Fatty liver is the hepatic manifestation of metabolic syndrome.
Andrea Dalbeni +6 more
openaire +3 more sources
Hyperreactivity of Blood Leukocytes in Patients with NAFLD to Ex Vivo Lipopolysaccharide Treatment Is Modulated by Metformin and Phosphatidylcholine but Not by Alpha Ketoglutarate. [PDF]
PLoS ONE, 2015 Toll-like receptor 4 and proinflammatory cytokines play a central role in the progression of nonalcoholic fatty liver disease. We investigated IL-1, IL-6 and TNFα production and toll-like receptor 4 in both--obese and lean patients with non-alcoholic ...
Agnieszka Zwolak +4 more
doaj +1 more source